| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.002 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.005 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.005 |